Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …

Hyperthyroidism is common, affecting approximately 2 percent of women and 0.2 percent of
men1. There are three principal treatments--antithyroid drugs, radioiodine, and surgery--all …

Graves' disease (GD) is a systemic autoimmune disorder characterized by the infiltration of
thyroid antigen-specific T cells into thyroid-stimulating hormone receptor (TSH-R) …

To analyze the benefits and risks of three common treatments, we randomly assigned 179
patients with Graves' hyperthyroidism as follows: 60 patients, 20-34 yr of age (young adults) …

Radioactive iodine (131I) has become the most widely used therapy for patients with
hyperthyroidism caused by Graves' disease in the United States. There remains, however …

There is little consensus regarding the most appropriate dose regimen for radioiodine (131I)
in the treatment of hyperthyroidism. We audited 813 consecutive hyperthyroid patients …

Radioiodine Therapy for Hyperthyroidism | New England Journal of Medicine Skip to main
content Access provided byST MARIANNA UNIV SCHOOL OF MEDICINE The New England …

The most common cause of thyrotoxicosis in children and adults is Graves' disease, an
autoimmune disorder characterized by diffuse goiter, hyperthyroidism and ophthalmopathy …

GRAVES'DISEASE IS CHARACTERIZED BY HYPERTHYROIDISM, diffuse goitre,
ophthalmopathy and, rarely, dermopathy. Although diagnostic testing is straightforward once …

The optimal method for determining iodine-131 treatment doses for Graves' hyperthyroidism
is unknown, and techniques have varied from a fixed dose to more elaborate calculations …